Form 4: Rocket Pharmaceuticals CEO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Gaurav Shah, CEO of Rocket Pharmaceuticals, sold 2,253 shares of common stock to cover tax withholding obligations related to vesting Restricted Stock Units.
Summary
- Gaurav Shah, the CEO of Rocket Pharmaceuticals, sold 2,253 shares of common stock on May 20, 2025.
- The sale was executed at a price of $6.446 per share.
- The transaction was conducted to cover tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs).
- Following the transaction, Shah directly owns 786,806 shares of Rocket Pharmaceuticals common stock.
- Shah also indirectly owns 207,897 shares through his spouse and 198,341 shares through the Gaurav D. Shah Irrevocable Trust.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the transaction is a routine sale to cover tax obligations and doesn't indicate a significant change in the executive's outlook on the company.
Industry Context
This is a routine transaction for executives to cover tax obligations related to equity compensation. It doesn't necessarily reflect a change in the executive's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 05/20/2025 | Date of stock sale transaction |
| 05/22/2025 | Date of signature on the Form 4 filing |
Keywords
Rocket Pharmaceuticals, Gaurav Shah, stock sale, Form 4, CEO, RSUs, tax obligations, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.